Laquinimod Sodium Salt
CAS: 248282-07-7
Ref. 3D-FL159548
| 1mg | Descatalogado | ||
| 2mg | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado |
Información del producto
Nombre:
Laquinimod Sodium Salt
Sinónimos:
- N-Ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide sodium salt
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt (1:1)
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt
- Laquinimod sodium
- ABR 215062 sodium
Descripción:
Laquinimod is a quinoline derivative that is used as a pharmaceutical preparation. It has been shown to be a potent inhibitor of the cb1 receptor, which is responsible for the inflammatory response. Laquinimod also inhibits the phosphorylation of focal adhesion kinase (FAK) and prostaglandin E2 production in mice with colitis. The drug has been shown to have anti-inflammatory effects in several animal models of inflammatory diseases, such as collagen-induced arthritis, experimental autoimmune encephalomyelitis (EAE), or chronic granulomatous disease.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
378.78 g/mol
Fórmula:
C19H16ClN2NaO3
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
